Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document



554.      Begg, A.C., Haustermans, K., Hart, A.A.M., Dische, S., Saunders, M. Zackrisson, B., Gustaffson, H., Coucke, P., Paschoud, N., Høyer, M., Overgaard, J., Antognoni, P., Richetti, A., Bourhis, J., Bartelink, H., Horiot, J.C., Corvo, R., Giaretti, W., Awwad, H., Shoumam, T., Jouffroy, T., Maciorowski, Z., Dubrowsky, W., Struikmans, H., Rutgers, D. & Willson, G.D.: The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.  Radiotherapy and Oncology 50: 13-24, 1999.

555.      Borre, M., Offersen, B., Nerstrøm, B. & Overgaard, J.: Angiogenese: Prognostisk markør ved cancer prostatae. Ugesr. Læg. 3832-3836, 1999.

556.      Breidahl, T.: The use of magnetic resonance spectroscopy to evaluate the anti-tumour activity of vascular damaging agents in a C3H mammary carcinoma Diploma study (Master of Medical Science) Faculty of Health Science, University of Aarhus, 1999.

557.      Ehrnrooth, E., von der Maase, H., Sørensen, B.S., Poulsen, J.H. & Horsman, M.R. The ability of hypoxia to modify the gene expression of thymidylate synthase in tumor cells in vivo. Int. J. Radiat. Biol. 75: 885-891, 1999.

558.      Hansen, J.B., Petersen, R.K, Larsen, B.M., Bartkova, J., Alsner, J. & Kristensen, K.: Activation of peroxisome proliferato-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation.  J. Biol. Chem. 274: 2386-2393, 1999.

559.      Højris, I.: Late morbidity following systemic treatment with or without postmastectomy irradiation in patients with breast cancer. Ph.D. Thesis, Faculty of Health Science, University of Aarhus,1999.

560.      Højris, I., Overgaard, M., Juul Christensen, J. & Overgaard, J.: Morbidity and mortality of ischaemic heart diseaase in high-risk breast cancer patients after adjuvant  postmastectomy systemic treatment with or without radiotherapy: analysis of the DBCG 82b and 82c randomized trials. Lancet 354: 1425-1430, 1999.

561.      Jørgensen, K. & Overgaard, J.: DAHANCA. Danish research projects in head and neck tumours. In: Brahe Petersen, C. & Bonding, P.  (eds)Otolaryngology in Denmark 1899-1999.  Danish Society of Otolaryngology Head and Neck Surgery, Aarhus pp. 91-105, 1999.

562.      Kasten, U., Plottner, N., Johansen, J., Overgaard, J. & Dikomey, E.: Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts. Brit. J. Cancer. 79: 1037-1041, 1999.

563.      Lundby, L., Hansen Dall, F., Gregersen, H., Overgaard, J. & Laurberg, S.: Distensibility of the mouse rectum application of impedance planimetry for stuying ange-related changes.  Colorectal Disease 1: 34-41, 1999.

564.      Nielsen, F.U., Topp, S., Horsman, M.R., Overgaard, J., Stødkilde-Jørgensen, H. & Maxwell, R.J.: Localised in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction. NMR in Biomed. 12: 175-183, 1999.

565.      Nordsmark, M. & Overgaard, J: Oxygenation of human tumours: The Aarhus experience. In Vaupel, P. & Kelleher, D.K. (eds). Tumor hypoxia: Pathophysiology, Clinical significance and Therapeutic perspectives. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1999).

566.      Overgaard, M., Jensen, M-B.,  Overgaard, J., Hansen, P.S., Rose, C., Andersson, M., Kamby, C., Kjær, M., Gadeberg, C.C., Bruun Rasmussen, B., Blichert-Toft, M. & Mouridsen, H.T.: Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Report from the Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641-1648.

567.      Raleigh, J.A., Chou, S.-C., Arteel, G.E. & Horsman, M.R. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumors. Radiat. Res. 151: 580-589, 1999.

568..     Stausbøl-Grøn, B., Bentzen, S.M., Jørgensen, K.E., Bundgaard T. & Overgaard, J.: In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data. Br. J. Cancer 79: 1074-1084, 1999.

569..     Stausbøl-Grøn, B. & Overgaard, J.: In vitro radiosensitivity of tumour cells has no predictive value for the radiation response of squameous cell carcinoma in the head and neck. Radiotherapy and Oncology 50: 47-55, 1999.

570.      Stausbøl-Grøn, B..: Radiosensitivity assessed by soft agar clonogenic assay in squamous cell carcinomas of the head and neck: Correlation with clinical data and treatment outcome. Ph.D. Thesis, Faculty of Health Science, University of Aarhus, 1999.

571.      Sørensen, S.B.:TP53 mutationer som prognostisk markør for hoved-hals cancer. M.S. thesis, Faculty of Natural Sciences, University of Aarhus, 1999.